Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Identifying Fall Risk of Patients Receiving Hematopoietic Cell Transplant

Identifying Fall Risk of Patients Receiving Hematopoietic Cell Transplant RESEARCH REPORT Identifying Fall Risk of Patients Receiving Hematopoietic Cell Transplant 1 2 3 3 3 Aaron B. Rindflesch, PT, PhD, NCS ; Melissa P. Hake, PT, DScPT ; Tanya Meyer ; Ryan Murphy ; Morgan L. Olson ; 3 4 Kayla Uphoff ; John H. Hollman, PT, PhD Assistant Professor of Physical Therapy, Department of Physical Medicine and Rehabilitation, Mayo Clinic, Rochester, MN; Clinical Education Coordinator, Department of Physical Medicine and Rehabilitation, Mayo Clinic, Rochester, MN; Student, Mayo Clinic School of Health Sciences, Mayo Clinic College of Medicine and Science, Rochester, MN; and Professor of Physical Therapy, Department of Physical Medicine and Rehabilitation, Mayo Clinic, Rochester, MN Background and Purpose/Objective: Few studies have examined the efficacy of fall risk assessment tools for patients undergoing hematopoietic cell transplant (HCT). The purpose of this study was to determine whether the Hendrich II Fall Risk Model (HFRM II) can distinguish patients who fell from those who did not fall in the inpatient HCT population. Methods: Observational study. Design: Retrospective chart review. Setting: Academic medical center. Patients: Patients undergoing HCT who fell during the first 100 days posttransplant. Intervention: None. Measurements: Independent-sample t tests were performed to determine differences in HFRM II http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Rehabilitation Oncology Wolters Kluwer Health

Identifying Fall Risk of Patients Receiving Hematopoietic Cell Transplant

Loading next page...
 
/lp/wolters-kluwer-health/identifying-fall-risk-of-patients-receiving-hematopoietic-cell-F954iJAHjW
Publisher
Wolters Kluwer Health
ISSN
2168-3808
eISSN
2381-2427
DOI
10.1097/01.REO.0000000000000113
Publisher site
See Article on Publisher Site

Abstract

RESEARCH REPORT Identifying Fall Risk of Patients Receiving Hematopoietic Cell Transplant 1 2 3 3 3 Aaron B. Rindflesch, PT, PhD, NCS ; Melissa P. Hake, PT, DScPT ; Tanya Meyer ; Ryan Murphy ; Morgan L. Olson ; 3 4 Kayla Uphoff ; John H. Hollman, PT, PhD Assistant Professor of Physical Therapy, Department of Physical Medicine and Rehabilitation, Mayo Clinic, Rochester, MN; Clinical Education Coordinator, Department of Physical Medicine and Rehabilitation, Mayo Clinic, Rochester, MN; Student, Mayo Clinic School of Health Sciences, Mayo Clinic College of Medicine and Science, Rochester, MN; and Professor of Physical Therapy, Department of Physical Medicine and Rehabilitation, Mayo Clinic, Rochester, MN Background and Purpose/Objective: Few studies have examined the efficacy of fall risk assessment tools for patients undergoing hematopoietic cell transplant (HCT). The purpose of this study was to determine whether the Hendrich II Fall Risk Model (HFRM II) can distinguish patients who fell from those who did not fall in the inpatient HCT population. Methods: Observational study. Design: Retrospective chart review. Setting: Academic medical center. Patients: Patients undergoing HCT who fell during the first 100 days posttransplant. Intervention: None. Measurements: Independent-sample t tests were performed to determine differences in HFRM II

Journal

Rehabilitation OncologyWolters Kluwer Health

Published: Jul 1, 2018

There are no references for this article.